ConductScience.org, home

Paper16809727

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.

Perez EA and 9 others. J Clin Oncol, 2006. Cited by 362 papers, by iCite.

Cite this record

ConductScience Library. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. Papers, record 16809727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16809727

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
PubMed
Journal
J Clin Oncol
PubMed
Year
2006
PubMed
Publication types
Evaluation Study, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
362
iCite
Relative citation ratio, by iCite
8.45
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perez EAEdith A
2Suman VJVera J
3Davidson NENancy E
4Martino SSilvana
5Kaufman PAPeter A
6Lingle WLWilma L
7Flynn PJPatrick J
8Ingle JNJames N
9Visscher DDaniel
10Jenkins RBRobert B

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Genes, erbB-2Major topic
ImmunohistochemistryMajor topic
In Situ Hybridization, FluorescenceMajor topic
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biomarkers, Tumor
Chemotherapy, Adjuvant
Female
Humans
Laboratories
Patient Selection
Predictive Value of Tests
Reproducibility of Results
Trastuzumab

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA25224NCI NIH HHSUnited StatesR10CA025224PubMed and NIHNIH RePORTER
U10CA025224NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17664462
The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.
https://conductscience.org/library/papers/17664462

Source PubMed

Download CSV of comments and corrections

Cited by145

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 362 citations.

PMIDTitleJournalYearIn PapersSource
42882335Detection Strategies for HER2 and miR-21 in Breast Cancer: Current Approaches and Future Perspectives- Hybrid Systematic Review and Bibliometric Mapping.Diagnostics (Basel)2026https://conductscience.org/library/papers/42882335PubMed
41402571HER2 expression in breast cancer: evidence gaps and challenges.NPJ Precis Oncol2025https://conductscience.org/library/papers/41402571PubMed
41296586Challenges & recommendations for identification of human epidermal growth factor receptor -2 (HER2)-low metastatic breast cancer in India: Expert opinion statement.Indian J Med Res2025https://conductscience.org/library/papers/41296586PubMed
39707103Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy.Breast Cancer Res Treat2025https://conductscience.org/library/papers/39707103PubMed
39470030Ultrasound Radiomics for the Prediction of Breast Cancers with HER2-Zero, -Low, and -Positive Status: A Dual-Center Study.Technol Cancer Res Treat2024https://conductscience.org/library/papers/39470030PubMed
38515821Hormone receptor conversion in metastatic breast cancer.Rep Pract Oncol Radiother2023https://conductscience.org/library/papers/38515821PubMed
38234171Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.Cancer Med2024https://conductscience.org/library/papers/38234171PubMed
37562195Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.ESMO Open2023https://conductscience.org/library/papers/37562195PubMed
37350943A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification.Front Oncol2023https://conductscience.org/library/papers/37350943PubMed
36627895Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.Cancer Drug Resist2022https://conductscience.org/library/papers/36627895PubMed
36030496Refining the definition of HER2-low class in invasive breast cancer.Histopathology2022https://conductscience.org/library/papers/36030496PubMed
35954438Targeted Approaches to HER2-Low Breast Cancer: Current Practice and Future Directions.Cancers (Basel)2022https://conductscience.org/library/papers/35954438PubMed
35458972Fine-Tuned DenseNet-169 for Breast Cancer Metastasis Prediction Using FastAI and 1-Cycle Policy.Sensors (Basel)2022https://conductscience.org/library/papers/35458972PubMed
35284307The prognostic effect of HER2 heterogeneity and YAP1 expression in HER2 positive breast cancer patients: a retrospective study.Gland Surg2022https://conductscience.org/library/papers/35284307PubMed
35223134A Novel Data Analytics-derived Metric (Nearest Cluster Distance) Is Easily Implemented in Routine Practice and Correctly Identifies Breast Cancer Cases for Quality Review.J Pathol Inform2022https://conductscience.org/library/papers/35223134PubMed
35208385Deep Learning-Enabled Technologies for Bioimage Analysis.Micromachines (Basel)2022https://conductscience.org/library/papers/35208385PubMed
35171393Blood Vessel Detection Algorithm for Tissue Engineering and Quantitative Histology.Ann Biomed Eng2022https://conductscience.org/library/papers/35171393PubMed
34868360mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.Oncol Lett2022https://conductscience.org/library/papers/34868360PubMed
34720807Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.Breast Care (Basel)2021https://conductscience.org/library/papers/34720807PubMed
34679544Comparison of BSGI and MRI as Approaches to Evaluating Residual Tumor Status after Neoadjuvant Chemotherapy in Chinese Women with Breast Cancer.Diagnostics (Basel)2021https://conductscience.org/library/papers/34679544PubMed

See all 145 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16809727

GET https://conductscience.org/api/papers/v1/16809727/cited_by?page=2